Public engagement and clinical trials: new models and disruptive technologies : workshop summary
Gespeichert in:
| Körperschaft: | |
|---|---|
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
Washington, D.C.
National Academies Press
2011
|
| Schlagworte: | |
| Online-Zugang: | FAW01 FAW02 Volltext |
| Beschreibung: | Includes bibliographical references (p. 85-87) "Clinical trials provide essential information needed to turn basic medical research findings into patient treatments. New treatments must be studied in large numbers of humans to find out whether they are effective and to assess any harm that may arise from treatment. There is growing recognition among many stakeholders that the U.S. clinical trials enterprise is unable to keep pace with the national demand for research results. The IOM, along with the Mount Sinai School of Medicine, held a workshop June 27-28, 2011, to engage stakeholders and experts in a discussion about possible solutions to improve public engagement in clinical trials"--Publisher's description Introduction -- - Framing the problem -- - Recruitment challenges in clinical trials for different diseases and conditions -- - Models for public health engagement -- - The media -- - Novel clinical trial designs -- - The health system's structure and culture -- - Toward a patient-centered strategy for clinical trials |
| Beschreibung: | 1 Online-Ressource (xvi, 124 p.) |
| ISBN: | 0309219299 0309219302 9780309219297 9780309219303 |
Internformat
MARC
| LEADER | 00000nmm a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV043151973 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 151126s2011 |||| o||u| ||||||eng d | ||
| 020 | |a 0309219299 |9 0-309-21929-9 | ||
| 020 | |a 0309219299 |c ebook |9 0-309-21929-9 | ||
| 020 | |a 0309219302 |c electronic bk. |9 0-309-21930-2 | ||
| 020 | |a 9780309219297 |c ebook |9 978-0-309-21929-7 | ||
| 020 | |a 9780309219303 |c electronic bk. |9 978-0-309-21930-3 | ||
| 035 | |a (OCoLC)769188485 | ||
| 035 | |a (DE-599)BVBBV043151973 | ||
| 040 | |a DE-604 |b ger |e aacr | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-1046 |a DE-1047 | ||
| 082 | 0 | |a 610.724 |2 23 | |
| 110 | 2 | |a Public Engagement and Clinical Trials: New Models and Disruptive Technologies <2011, Mount Sinai School of Medicine> |e Verfasser |4 aut | |
| 245 | 1 | 0 | |a Public engagement and clinical trials |b new models and disruptive technologies : workshop summary |c Victoria Weisfeld, Rebecca A. English, and Anne B. Claiborne, rapporteurs ; Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine of the National Academies |
| 264 | 1 | |a Washington, D.C. |b National Academies Press |c 2011 | |
| 300 | |a 1 Online-Ressource (xvi, 124 p.) | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 500 | |a Includes bibliographical references (p. 85-87) | ||
| 500 | |a "Clinical trials provide essential information needed to turn basic medical research findings into patient treatments. New treatments must be studied in large numbers of humans to find out whether they are effective and to assess any harm that may arise from treatment. There is growing recognition among many stakeholders that the U.S. clinical trials enterprise is unable to keep pace with the national demand for research results. The IOM, along with the Mount Sinai School of Medicine, held a workshop June 27-28, 2011, to engage stakeholders and experts in a discussion about possible solutions to improve public engagement in clinical trials"--Publisher's description | ||
| 500 | |a Introduction -- - Framing the problem -- - Recruitment challenges in clinical trials for different diseases and conditions -- - Models for public health engagement -- - The media -- - Novel clinical trial designs -- - The health system's structure and culture -- - Toward a patient-centered strategy for clinical trials | ||
| 650 | 7 | |a MEDICAL / Laboratory Medicine |2 bisacsh | |
| 650 | 7 | |a Clinical trials |2 fast | |
| 650 | 4 | |a Clinical Trials as Topic / United States | |
| 650 | 4 | |a Patient Participation / United States | |
| 650 | 4 | |a Patient Education as Topic / United States | |
| 650 | 4 | |a Drug Evaluation / United States | |
| 650 | 4 | |a Medizin | |
| 650 | 4 | |a Clinical trials | |
| 651 | 4 | |a USA | |
| 700 | 1 | |a Weisfeld, Victoria D. |e Sonstige |4 oth | |
| 700 | 1 | |a English, Rebecca A. |e Sonstige |4 oth | |
| 700 | 1 | |a Claiborne, Anne B. |e Sonstige |4 oth | |
| 710 | 2 | |a Institute of Medicine (U.S.) |b Forum on Drug Discovery, Development, and Translation |e Sonstige |4 oth | |
| 856 | 4 | 0 | |u http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=400080 |x Aggregator |3 Volltext |
| 912 | |a ZDB-4-EBA | ||
| 999 | |a oai:aleph.bib-bvb.de:BVB01-028576164 | ||
| 966 | e | |u http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=400080 |l FAW01 |p ZDB-4-EBA |q FAW_PDA_EBA |x Aggregator |3 Volltext | |
| 966 | e | |u http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=400080 |l FAW02 |p ZDB-4-EBA |q FAW_PDA_EBA |x Aggregator |3 Volltext | |
Datensatz im Suchindex
| _version_ | 1804175612692135936 |
|---|---|
| any_adam_object | |
| author_corporate | Public Engagement and Clinical Trials: New Models and Disruptive Technologies <2011, Mount Sinai School of Medicine> |
| author_corporate_role | aut |
| author_facet | Public Engagement and Clinical Trials: New Models and Disruptive Technologies <2011, Mount Sinai School of Medicine> |
| author_sort | Public Engagement and Clinical Trials: New Models and Disruptive Technologies <2011, Mount Sinai School of Medicine> |
| building | Verbundindex |
| bvnumber | BV043151973 |
| collection | ZDB-4-EBA |
| ctrlnum | (OCoLC)769188485 (DE-599)BVBBV043151973 |
| dewey-full | 610.724 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 610 - Medicine and health |
| dewey-raw | 610.724 |
| dewey-search | 610.724 |
| dewey-sort | 3610.724 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03585nmm a2200553zc 4500</leader><controlfield tag="001">BV043151973</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">151126s2011 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0309219299</subfield><subfield code="9">0-309-21929-9</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0309219299</subfield><subfield code="c">ebook</subfield><subfield code="9">0-309-21929-9</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0309219302</subfield><subfield code="c">electronic bk.</subfield><subfield code="9">0-309-21930-2</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780309219297</subfield><subfield code="c">ebook</subfield><subfield code="9">978-0-309-21929-7</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780309219303</subfield><subfield code="c">electronic bk.</subfield><subfield code="9">978-0-309-21930-3</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)769188485</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV043151973</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-1046</subfield><subfield code="a">DE-1047</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610.724</subfield><subfield code="2">23</subfield></datafield><datafield tag="110" ind1="2" ind2=" "><subfield code="a">Public Engagement and Clinical Trials: New Models and Disruptive Technologies <2011, Mount Sinai School of Medicine></subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Public engagement and clinical trials</subfield><subfield code="b">new models and disruptive technologies : workshop summary</subfield><subfield code="c">Victoria Weisfeld, Rebecca A. English, and Anne B. Claiborne, rapporteurs ; Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine of the National Academies</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Washington, D.C.</subfield><subfield code="b">National Academies Press</subfield><subfield code="c">2011</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (xvi, 124 p.)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references (p. 85-87)</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">"Clinical trials provide essential information needed to turn basic medical research findings into patient treatments. New treatments must be studied in large numbers of humans to find out whether they are effective and to assess any harm that may arise from treatment. There is growing recognition among many stakeholders that the U.S. clinical trials enterprise is unable to keep pace with the national demand for research results. The IOM, along with the Mount Sinai School of Medicine, held a workshop June 27-28, 2011, to engage stakeholders and experts in a discussion about possible solutions to improve public engagement in clinical trials"--Publisher's description</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Introduction -- - Framing the problem -- - Recruitment challenges in clinical trials for different diseases and conditions -- - Models for public health engagement -- - The media -- - Novel clinical trial designs -- - The health system's structure and culture -- - Toward a patient-centered strategy for clinical trials</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL / Laboratory Medicine</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Clinical trials</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Clinical Trials as Topic / United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Patient Participation / United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Patient Education as Topic / United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Evaluation / United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medizin</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Clinical trials</subfield></datafield><datafield tag="651" ind1=" " ind2="4"><subfield code="a">USA</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Weisfeld, Victoria D.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">English, Rebecca A.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Claiborne, Anne B.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="710" ind1="2" ind2=" "><subfield code="a">Institute of Medicine (U.S.)</subfield><subfield code="b">Forum on Drug Discovery, Development, and Translation</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=400080</subfield><subfield code="x">Aggregator</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-4-EBA</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-028576164</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=400080</subfield><subfield code="l">FAW01</subfield><subfield code="p">ZDB-4-EBA</subfield><subfield code="q">FAW_PDA_EBA</subfield><subfield code="x">Aggregator</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=400080</subfield><subfield code="l">FAW02</subfield><subfield code="p">ZDB-4-EBA</subfield><subfield code="q">FAW_PDA_EBA</subfield><subfield code="x">Aggregator</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
| geographic | USA |
| geographic_facet | USA |
| id | DE-604.BV043151973 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-10T07:19:04Z |
| institution | BVB |
| isbn | 0309219299 0309219302 9780309219297 9780309219303 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-028576164 |
| oclc_num | 769188485 |
| open_access_boolean | |
| owner | DE-1046 DE-1047 |
| owner_facet | DE-1046 DE-1047 |
| physical | 1 Online-Ressource (xvi, 124 p.) |
| psigel | ZDB-4-EBA ZDB-4-EBA FAW_PDA_EBA |
| publishDate | 2011 |
| publishDateSearch | 2011 |
| publishDateSort | 2011 |
| publisher | National Academies Press |
| record_format | marc |
| spelling | Public Engagement and Clinical Trials: New Models and Disruptive Technologies <2011, Mount Sinai School of Medicine> Verfasser aut Public engagement and clinical trials new models and disruptive technologies : workshop summary Victoria Weisfeld, Rebecca A. English, and Anne B. Claiborne, rapporteurs ; Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine of the National Academies Washington, D.C. National Academies Press 2011 1 Online-Ressource (xvi, 124 p.) txt rdacontent c rdamedia cr rdacarrier Includes bibliographical references (p. 85-87) "Clinical trials provide essential information needed to turn basic medical research findings into patient treatments. New treatments must be studied in large numbers of humans to find out whether they are effective and to assess any harm that may arise from treatment. There is growing recognition among many stakeholders that the U.S. clinical trials enterprise is unable to keep pace with the national demand for research results. The IOM, along with the Mount Sinai School of Medicine, held a workshop June 27-28, 2011, to engage stakeholders and experts in a discussion about possible solutions to improve public engagement in clinical trials"--Publisher's description Introduction -- - Framing the problem -- - Recruitment challenges in clinical trials for different diseases and conditions -- - Models for public health engagement -- - The media -- - Novel clinical trial designs -- - The health system's structure and culture -- - Toward a patient-centered strategy for clinical trials MEDICAL / Laboratory Medicine bisacsh Clinical trials fast Clinical Trials as Topic / United States Patient Participation / United States Patient Education as Topic / United States Drug Evaluation / United States Medizin Clinical trials USA Weisfeld, Victoria D. Sonstige oth English, Rebecca A. Sonstige oth Claiborne, Anne B. Sonstige oth Institute of Medicine (U.S.) Forum on Drug Discovery, Development, and Translation Sonstige oth http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=400080 Aggregator Volltext |
| spellingShingle | Public engagement and clinical trials new models and disruptive technologies : workshop summary MEDICAL / Laboratory Medicine bisacsh Clinical trials fast Clinical Trials as Topic / United States Patient Participation / United States Patient Education as Topic / United States Drug Evaluation / United States Medizin Clinical trials |
| title | Public engagement and clinical trials new models and disruptive technologies : workshop summary |
| title_auth | Public engagement and clinical trials new models and disruptive technologies : workshop summary |
| title_exact_search | Public engagement and clinical trials new models and disruptive technologies : workshop summary |
| title_full | Public engagement and clinical trials new models and disruptive technologies : workshop summary Victoria Weisfeld, Rebecca A. English, and Anne B. Claiborne, rapporteurs ; Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine of the National Academies |
| title_fullStr | Public engagement and clinical trials new models and disruptive technologies : workshop summary Victoria Weisfeld, Rebecca A. English, and Anne B. Claiborne, rapporteurs ; Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine of the National Academies |
| title_full_unstemmed | Public engagement and clinical trials new models and disruptive technologies : workshop summary Victoria Weisfeld, Rebecca A. English, and Anne B. Claiborne, rapporteurs ; Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine of the National Academies |
| title_short | Public engagement and clinical trials |
| title_sort | public engagement and clinical trials new models and disruptive technologies workshop summary |
| title_sub | new models and disruptive technologies : workshop summary |
| topic | MEDICAL / Laboratory Medicine bisacsh Clinical trials fast Clinical Trials as Topic / United States Patient Participation / United States Patient Education as Topic / United States Drug Evaluation / United States Medizin Clinical trials |
| topic_facet | MEDICAL / Laboratory Medicine Clinical trials Clinical Trials as Topic / United States Patient Participation / United States Patient Education as Topic / United States Drug Evaluation / United States Medizin USA |
| url | http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=400080 |
| work_keys_str_mv | AT publicengagementandclinicaltrialsnewmodelsanddisruptivetechnologies2011mountsinaischoolofmedicine publicengagementandclinicaltrialsnewmodelsanddisruptivetechnologiesworkshopsummary AT weisfeldvictoriad publicengagementandclinicaltrialsnewmodelsanddisruptivetechnologiesworkshopsummary AT englishrebeccaa publicengagementandclinicaltrialsnewmodelsanddisruptivetechnologiesworkshopsummary AT claiborneanneb publicengagementandclinicaltrialsnewmodelsanddisruptivetechnologiesworkshopsummary AT instituteofmedicineusforumondrugdiscoverydevelopmentandtranslation publicengagementandclinicaltrialsnewmodelsanddisruptivetechnologiesworkshopsummary |